Two Sigma Securities’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.7K Buy
+13,019
New +$13.7K ﹤0.01% 1467
2024
Q3
Sell
-521
Closed -$4.83K 3493
2024
Q2
$4.83K Buy
521
+59
+13% +$655 ﹤0.01% 2861
2024
Q1
$6.12K Buy
+462
New +$8.24K ﹤0.01% 2817
2023
Q4
Sell
-1,015
Closed -$12.9K 3478
2023
Q3
$12.9K Buy
1,015
+489
+93% +$12.8K ﹤0.01% 2648
2023
Q2
$15.8K Buy
+526
New +$30.3K ﹤0.01% 2536
2022
Q3
Sell
-15
Closed -$13K 3008
2022
Q2
$13K Sell
15
-10
-40% -$13.7K ﹤0.01% 2019
2022
Q1
$64K Buy
25
+4
+19% +$9.48K ﹤0.01% 1849
2021
Q4
$55K Buy
+21
New +$84K ﹤0.01% 1263

Other funds holding RDHL

Two Sigma Securities's RDHL Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Redhill Biopharma (RDHL) in Q1 2026: 13,019 shares worth $9.7K. The stake represents ﹤0.01% of the portfolio and ranks #1467 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in RDHL as recently as Q2 2024.

Two Sigma Securities first reported a position in RDHL in Q4 2021 and has held it in 8 quarters since. The position peaked at $64K in Q1 2022. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.

  • Two Sigma Securities held 13,019 shares of Redhill Biopharma worth $9.7K as of Q1 2026.
  • Redhill Biopharma was a new Two Sigma Securities position in Q1 2026.
  • Redhill Biopharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1467 holding.
  • Two Sigma Securities first reported a position in Redhill Biopharma in Q4 2021 and has held it in 8 quarters since.
  • Two Sigma Securities's Redhill Biopharma position peaked at $64K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.